https://www.businesswire.com/news/home/20180305005966/en/City-Hope-Study...
"City of Hope researchers aimed to find a treatment for CML that was effective enough for people to stop using TKIs. In their quest to find a cure for the disease, the team tested a drug called miristen. Developed at City of Hope, miristen targets one type of a microRNA that is expressed in leukemia stem cells, known as miR-126, and researchers believed to be important for self-renewal and persistence of stubborn leukemia stem cells"